Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H
EMBO J. 1984; 3(5):1151-7.
PMID: 6329740
PMC: 557488.
DOI: 10.1002/j.1460-2075.1984.tb01944.x.
Howley P
Am J Pathol. 1983; 113(3):414-21.
PMID: 6316792
PMC: 1916352.
Geissler E, Theile M
Hum Genet. 1983; 63(1):1-12.
PMID: 6299926
DOI: 10.1007/BF00285389.
NASSERI M, WETTSTEIN F, Stevens J
J Virol. 1982; 44(1):263-8.
PMID: 6292489
PMC: 256261.
DOI: 10.1128/JVI.44.1.263-268.1982.
Lancaster W, Olson C
Microbiol Rev. 1982; 46(2):191-207.
PMID: 6289064
PMC: 281538.
DOI: 10.1128/mr.46.2.191-207.1982.
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells.
Turek L, Byrne J, Lowy D, Dvoretzky I, Friedman R, Howley P
Proc Natl Acad Sci U S A. 1982; 79(24):7914-8.
PMID: 6185955
PMC: 347460.
DOI: 10.1073/pnas.79.24.7914.
Transcriptional organization of bovine papillomavirus type 1.
Engel L, Heilman C, Howley P
J Virol. 1983; 47(3):516-28.
PMID: 6137574
PMC: 255293.
DOI: 10.1128/JVI.47.3.516-528.1983.
Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.
Esposito J, Brechling K, Baer G, Moss B
Virus Genes. 1987; 1(1):7-21.
PMID: 3508340
DOI: 10.1007/BF00125682.
Cervical papillomaviruses segregate within morphologically distinct precancerous lesions.
Crum C, Mitao M, LEVINE R, Silverstein S
J Virol. 1985; 54(3):675-81.
PMID: 2987521
PMC: 254851.
DOI: 10.1128/JVI.54.3.675-681.1985.
Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors.
Lusky M, Botchan M
J Virol. 1985; 53(3):955-65.
PMID: 2983102
PMC: 254732.
DOI: 10.1128/JVI.53.3.955-965.1985.
Evidence that replication initiates at only some of the potential origins in each oligomeric form of bovine papillomavirus type 1 DNA.
Schvartzman J, Adolph S, Martin-Parras L, SCHILDKRAUT C
Mol Cell Biol. 1990; 10(6):3078-86.
PMID: 2160593
PMC: 360672.
DOI: 10.1128/mcb.10.6.3078-3086.1990.
